What is the history of Hydranencephaly?

TL;DR: Hydranencephaly was first formally described in the early 19th century as a condition where the cerebral hemispheres are replaced by cerebrospinal fluid-filled sacs. While historically considered a developmental defect, modern neurology and neuroimaging have clarified that hydranencephaly is typically the result of a destructive vascular event, such as an occlusion of the internal carotid arteries, occurring during fetal development.

When was hydranencephaly first described?

The medical literature began to document cases of hydranencephaly in the early 1800s. Early physicians often struggled to differentiate it from severe hydrocephalus, leading to significant diagnostic confusion. The term "hydranencephaly" itself was coined later, in 1946, by Dr. Wilder Penfield and Dr. W.V. Cone, who sought to distinguish this specific clinical entity from other forms of fluid accumulation in the skull. Before this, the condition was frequently termed "anencephaly with intact skull" or "hydroanencephaly," reflecting the limited diagnostic tools available to those early practitioners.

How has our understanding of the cause of hydranencephaly evolved?

For many decades, hydranencephaly was erroneously viewed as a primary failure of brain development (malformation). However, as neuropathology advanced in the mid-20th century, researchers recognized that the brain structures were often formed normally before being destroyed. This shift in understanding was driven by the realization that hydranencephaly is likely an acquired, catastrophic event. Key theories regarding the etiology include:

• Vascular Occlusion: The most widely accepted theory is that an interruption of blood flow, particularly via the internal carotid arteries, leads to necrosis of the cerebral hemispheres.


• Infection and Trauma: Historical data suggests that intrauterine infections (such as cytomegalovirus or toxoplasmosis) or maternal trauma can trigger the vascular events leading to hydranencephaly.


• Twin-to-Twin Transfusion: In rare instances, vascular complications in twin pregnancies have been identified as a contributing factor.

What historical milestones changed the diagnosis and management of the condition?

The history of hydranencephaly is defined by the transition from clinical observation to advanced imaging. The introduction of transillumination of the skull in the 1950s allowed physicians to quickly identify the fluid-filled cavities at the bedside. Later, the advent of ultrasound and fetal MRI revolutionized our ability to detect hydranencephaly in utero. These technological leaps moved the conversation from post-mortem diagnosis to prenatal counseling and palliative care planning, allowing families to make informed decisions earlier in the pregnancy.

How have patient advocacy and awareness changed?

Historically, families affected by hydranencephaly were often isolated, with little access to support networks. The rise of rare disease organizations, including the community here at DiseaseMaps.org, has been instrumental in changing this narrative. With 37 members currently sharing their lived experiences, the focus has shifted toward improving the quality of life, understanding palliative care, and fostering a community that provides emotional support to families navigating the complexities of this diagnosis. Modern advocacy emphasizes that while the prognosis for hydranencephaly remains severe, the dignity and comfort of the affected individual are paramount.

Next steps

• Consult with a pediatric neurologist or a neonatologist to discuss the specific clinical presentation of your loved one.


• Connect with the 37 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Seek guidance from a palliative care team specializing in complex neurological conditions to ensure the highest quality of life.


• Utilize resources from the NIH Genetic and Rare Diseases (GARD) Information Center for the most current clinical updates.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always consult with a qualified healthcare provider regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Hydranencephaly Overview.


• Orphanet: Rare Disease Database (ORPHA: 418).


• Penfield, W., & Cone, W. V. (1946). "Hydranencephaly." Archives of Neurology & Psychiatry.


• OMIM (Online Mendelian Inheritance in Man): Clinical entries related to cerebral destructive disorders.